(Q35982514)

English

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

scientific article published on January 1, 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

10.1038/BJC.1991.30

https://api.crossref.org/works/10.1038/BJC.1991.30

8 December 2022

10

object named as

A. L. Harris

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

author name string

S. Nicholson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

J. Richard

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

C. Sainsbury

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

P. Halcrow

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

P. Kelly

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

B. Angus

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

C. Wright

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

J. Henry

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

J. R. Farndon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

language of work or name

0 references

publication date

1 January 1991

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

full work available at URL

https://europepmc.org/articles/PMC1971641

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

https://europepmc.org/articles/PMC1971641?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846551

8 December 2022

http://www.nature.com/articles/bjc199130.pdf

Portable Document Format

1 reference

10.1038/BJC.1991.30

https://api.crossref.org/works/10.1038/BJC.1991.30

8 December 2022

http://www.nature.com/articles/bjc199130

1 reference

10.1038/BJC.1991.30

https://api.crossref.org/works/10.1038/BJC.1991.30

8 December 2022

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

63

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

146-150

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Current status of adjuvant chemotherapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Oestrogen receptors and prognosis in early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

2 October 2017

Cell kinetics as a prognostic marker in node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

11 July 2018

Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

11 July 2018

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

11 July 2018

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

11 July 2018

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971641

11 July 2018

Epidermal growth factor receptors in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New storage procedure for human tumor biopsies prior to estrogen receptor measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant CMF chemotherapy in operable breast cancer: ten years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/1846551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1991.30

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35982514&oldid=2198024156"